http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 25 Mar 2022 04:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Fri, 25 Mar 2022 04:00:00 -0400 A.10141387 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Fri, 25 Mar 2022 04:00:00 -0400 A.10141387 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Fri, 25 Mar 2022 04:00:00 -0400 A.10141387 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Fri, 25 Mar 2022 04:00:00 -0400 A.10141387 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Fri, 25 Mar 2022 04:00:00 -0400 A.10141387 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Reports+Continued+Strategic+and+Operational+Momentum+for+12+Months+ended+31+December+2021/19822940.html Fri, 25 Mar 2022 04:00:00 -0400 A.10141387 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Announces+a+License+Option+Agreement+with+University+of+Michigan/19763933.html Fri, 11 Mar 2022 12:21:00 -0400 A.10141387 A.24904667 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html for the full story. http://www.streetinsider.com/PRNewswire/OncoArendi+Therapeutics+Appoints+Dr.+Adam+Go%C5%82%C4%99biowski%2C+Dr.+Zbigniew+Zas%C5%82ona+and+Agnieszka+Rajczuk-Szczepa%C5%84ska+to+its+Management+Board/19527804.html Mon, 31 Jan 2022 07:52:00 -0400 A.10141387 A.12512883 A.21732375 OAT OAT http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Samson+Fung%2C+M.D.+as+Chief+Medical+Officer/19512347.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Samson+Fung%2C+M.D.+as+Chief+Medical+Officer/19512347.html for the full story. http://www.streetinsider.com/Press+Releases/OncoArendi+Therapeutics+Appoints+Samson+Fung%2C+M.D.+as+Chief+Medical+Officer/19512347.html Thu, 27 Jan 2022 06:53:00 -0400 A.41940240 OAT